Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes.

about

Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients.Investigating a multigene prognostic assay based on significant pathways for Luminal A breast cancer through gene expression profile analysis.

P2860

Q37691082-759456E7-A5B4-4F60-A851-284308852AB8 Q52653031-22D786EB-9443-4C22-B639-5C9C5286B756

P2860

Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes.

Item

http://www.wikidata.org/entity/Q40600342

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Risk Differences Between Predi ...... ast Cancer Molecular Subtypes.

@en

type

Item

label

Risk Differences Between Predi ...... ast Cancer Molecular Subtypes.

@en

prefLabel

Risk Differences Between Predi ...... ast Cancer Molecular Subtypes.

@en

P1476

Risk Differences Between Predi ...... east Cancer Molecular Subtypes

@en

P2093

A Giudice

http://www.w3.org/2001/XMLSchema#string

D J A Jenkins

http://www.w3.org/2001/XMLSchema#string

E Cavalcanti

http://www.w3.org/2001/XMLSchema#string

E Esposito

http://www.w3.org/2001/XMLSchema#string

F Nocerino

http://www.w3.org/2001/XMLSchema#string

G Riccardi

http://www.w3.org/2001/XMLSchema#string

L S A Augustin

http://www.w3.org/2001/XMLSchema#string

M Di Bonito

http://www.w3.org/2001/XMLSchema#string

M Grimaldi

http://www.w3.org/2001/XMLSchema#string

M Libra

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidative Decay of DNA

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

The pathobiology of diabetic complications: a unifying mechanism

Standards of medical care in diabetes--2013

Hyperglycemia enhances the proliferation of non-tumorigenic and malignant mammary epithelial cells through increased leptin/IGF1R signaling and activation of AKT/mTOR.

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

P304

1144-1150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.25579

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

232

http://www.w3.org/2001/XMLSchema#string

P50

Anna Crispo

Gennaro Ciliberto

Michelino De Laurentiis

G Botti

Alfonso Amore

P577

2016-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27579809

http://www.w3.org/2001/XMLSchema#string

Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes.

about

P2860

P2860

Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698